• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
73,832.55 -150.63
( -0.20%)
Global Indices
Nasdaq
50,865.93 926.15
(1.85%)
Dow Jones
7,414.60 126.61
(1.74%)
Hang Seng
64,050.08 -129.19
(-0.20%)
Nikkei 225
10,316.43 61.62
(0.60%)
Forex
USD-INR
95.41 -0.12
(-0.12%)
EUR-INR
110.18 0.04
(0.03%)
GBP-INR
127.60 0.17
(0.13%)
JPY-INR
0.60 0.00
(-0.17%)

EQUITY - MARKET SCREENER

Supriya Lifescience Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
543434
INE07RO01027
148.8189477
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUPRIYA
35.96
7534.4
EPS(TTM)
Face Value()
Div & Yield %
26.03
2
0.11
 

kcd industries india ltd
Alka India reports consolidated net profit of Rs 0.82 crore in the March 2026 quarter
Apr 08,2026
Net profit of Alka India reported to Rs 0.82 crore in the quarter ended March 2026 as against net loss of Rs 0.38 crore during the previous quarter ended March 2025. Sales reported to Rs 2.50 crore in the quarter ended March 2026. There were no Sales reported during the previous quarter ended March 2025.

For the full year,net profit reported to Rs 0.18 crore in the year ended March 2026 as against net loss of Rs 0.44 crore during the previous year ended March 2025. Sales reported to Rs 2.50 crore in the year ended March 2026. There were no Sales reported during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales2.500 0 2.500 0
OPM %32.400 -6.800 -
PBDT0.82-0.38 LP 0.18-0.44 LP
PBT0.82-0.38 LP 0.18-0.44 LP
NP0.82-0.38 LP 0.18-0.44 LP